Related Experiment Video

Updated: May 8, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Prohibitin-2 binding modulates insulin-like growth factor-binding protein-6 (IGFBP-6)-induced rhabdomyosarcoma cell

Ping Fu1, Zhiyong Yang, Leon A Bach

  • 1From the Department of Medicine, Central Clinical School, Monash University, Alfred Medical Research and Education Precinct, Prahran, Victoria 3181, Australia and.

The Journal of Biological Chemistry
|September 5, 2013
PubMed

Insights

Insulin-like growth factor-binding protein 6 (IGFBP-6) drives rhabdomyosarcoma cell migration by interacting with prohibitin-2 (PHB2). This interaction is crucial for IGFBP-6

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • Insulin-like growth factor (IGF)-binding protein (IGFBP)-6 traditionally inhibits IGF-II effects on cancer cells.
  • Recent findings indicate IGFBP-6 promotes rhabdomyosarcoma (RMS) cell migration independently of IGF-II, involving MAPK pathways.
  • The exact molecular mechanisms behind IGFBP-6's IGF-independent migratory role remain unclear.

Purpose of the Study:

  • To elucidate the molecular mechanisms underlying IGFBP-6-induced RMS cell migration.
  • To identify key proteins interacting with IGFBP-6 in an IGF-independent manner.
  • To investigate the role of prohibitin-2 (PHB2) in IGFBP-6-mediated RMS cell migration.

Main Methods:

  • Co-localization studies using confocal microscopy.
  • Protein-protein interaction analysis via affinity chromatography and co-immunoprecipitation.
  • Biosensor analysis to determine binding affinities.
  • PHB2 knockdown experiments to assess functional impact.
  • MAPK pathway activation assays.

Main Results:

  • Prohibitin-2 (PHB2) and IGFBP-6 were found to co-localize and specifically interact on the RMS cell surface.
  • The C-domain of IGFBP-6 was identified as the region responsible for PHB2 binding.
  • IGFBP-6 binding to PHB2 led to indirect tyrosine phosphorylation of PHB2.
  • Knockdown of PHB2 completely abrogated IGFBP-6-induced RMS cell migration.
  • MAPK pathway activation by IGFBP-6 was unaffected by PHB2 knockdown, suggesting PHB2 acts downstream.

Conclusions:

  • Prohibitin-2 (PHB2) is a critical mediator of IGFBP-6-induced rhabdomyosarcoma cell migration in an IGF-independent manner.
  • The interaction between IGFBP-6 and PHB2, along with PHB2 phosphorylation, is essential for this migratory effect.
  • PHB2 may function as a downstream effector in IGFBP-6-mediated signaling pathways.
  • PHB2 represents a potential therapeutic target for rhabdomyosarcoma treatment.
Keywords:
Cell MigrationInsulin-like Growth Factor (IGF)Insulin-like Growth Factor-binding Protein-6Prohibitin-2Protein PhosphorylationProtein-Protein InteractionsRhabdomyosarcoma

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...